Overview of Reopro.com
Reopro.com was first analyzed by us on Jun 22, 2013.
We can see that the website is OFFLINE.
It currently ranks #118,128 in the world according to Alexa.
The lower the Alexa Rank, the better and this is in our opinion a great rank.
It is most popular in United States where it currently ranks #35,971.
The website has a good Google PageRank of 5.
Name: |
Reopro |
Website URL: |
www.reopro.com |
Page Rank: |
 |
Alexa Rank: |
#118,128
|
Country Rank: |
#35,971 |
Most Popular In: |
United States |
Website Speed: |
0 seconds |
Language: |
English |
IP Address: |
|
Back Links (Alexa) |
2,645 |
Popular Keywords: |
Reopro, Patients, Bleeding, Lilly, Information, Intervention, Use
|
Websites Like Reopro.com
Website Owner Information
We have extracted information from different sources about the ownership of reopro.com.
Owner: |
Eli Lilly and Company |
Phone: |
+1 973 898 9505 |
Address: |
1 Sylvan Way, Parsippany, NJ, 07054, US |
Social Statistics
Facebook Stats |
Likes: |
0 |
Shares: |
0 |
Clicks: |
0 |
Comments: |
0 |
Website's On-page Analysis
We did not crawl this website full for on-page analysis. Please use the refresh button above to update this record.
HTML Tag Elements |
Paragraph: |
0 |
Strong: |
0 |
Tables: |
0 |
Lists: |
0 |
Total Images: |
0 |
Missing Alt: |
0 |
Internal Links: |
0 |
External Links: |
0 |
Forms: |
0 |
Fields: |
0 |
Page Headings |
H1 Tags: |
0 |
H2 Tags: |
0 |
H3 Tags: |
0 |
H4 Tags: |
0 |
H5 Tags: |
0 |
H6 Tags: |
0 |
Includes |
Iframe: |
0 |
Flash: |
0 |
CSS: |
0 |
Scripts: |
0 |
Page Statistics |
File Size: |
KB |
Word Count: |
0 |
Charset: |
|
Doctype: |
No |
Viewport: |
No |
Google Analytics: |
No |
Webmaster Tools: |
No |
Bing Webmaster Tools: |
No |
Meta elements are HTML elements used to provide structured metadata about a Web page.
We have listed below the meta elements we have extracted from reopro.com.
Name |
Contents |
Title Tag: |
ReoPro.com -
Home Page - Provideed by Eli Lilly and Company |
Description Tag: |
ReoPro(Abciximab) is a monoclonal antibody that blocks the pathway to platelet aggregation and reduces cardiac ischemic complications in patients undergoing PCI (percutaneous coronary intervention). |
Keywords Tag: |
Reopro.com, Reopro, Abciximab, monoclonal antibody, cardiac ischemic complications, PCI, primary percutaneous coronary intervention, platelet aggregation, diabetic patients, Eli Lilly and Company, Lilly |
Traffic Report
Alexa Global Rank: |
|
Compete: |
|
Quantcast: |
|
Website WOT Rating
WOT is a website reputation system that identifies trustworthy websites and protects against online scams, untrustworthy links, and unreliable web stores.
Reputation ratings are based on real user ratings and they tell you how much other users trust this site.
Description |
Score |
Confidence |
Trustworthiness: |
60/100 - Good |
2/100 - |
Keyword Analysis
We have attempted to list all keywords that have been repeated more than once and are topic related.
# |
Keyword |
Repeated |
1 | reopro | 29 |
2 | patients | 17 |
3 | bleeding | 11 |
4 | lilly | 10 |
5 | information | 9 |
6 | intervention | 7 |
7 | use | 2 |
8 | readministration | 2 |
9 | pci | 2 |
10 | within | 2 |
11 | heparin | 2 |
Add a widget to your website to gain more user confidence. Just copy & paste the html snippet into your website!